Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry.
J Mass Spectrom Adv Clin Lab
; 25: 53-60, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35910410
EMA, European Medicines Agency; IDA, Information dependent acqusition; IgG1, immunoglobulin G1; LC-MS/MS; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; MS, Multiple sclerosis; MWCO, molecular weight cut-off; Multiple sclerosis; OVERLORD-MS, Ocrelizumab vErsus Rituximab Off-Label at the Onset of Relapsing MS; Ocrelizumab; QTOF, quadrupole time-of-flight; QTRAP, quadrupole ion trap; ROS-MS, Rituximab and Ocrelizumab in Serum with Multiple Sclerosis study; TDM, therapeutic drug monitoring; Therapeutic drug monitoring; Therapeutic monoclonal antibodies; UHPLC, ultra high performance liquid chromatography; t-mAb, therapeutic monoclonal antibody
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Mass Spectrom Adv Clin Lab
Year:
2022
Document type:
Article
Affiliation country:
Norway